Pulmonx's average Accounts Receivable for the
three
months ended in Mar. 2024 was $11.31 Mil. Pulmonx's Revenue for the
three
months ended in Mar. 2024 was $18.85 Mil.
Hence, Pulmonx's Days Sales Outstanding for the
three
months ended in Mar. 2024 was 54.76.
The historical rank and industry rank for Pulmonx's Days Sales Outstanding or its related term are showing as below:
LUNG'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.67 Med: 52.83 Max: 55.23
Current: 49.83
During the past 6 years, Pulmonx's highest Days Sales Outstanding was 55.23. The lowest was 40.67. And the median was 52.83.
LUNG's Days Sales Outstanding is ranked better than 69.02% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 64.21
vs LUNG: 49.83
Pulmonx's Days Sales Outstanding
increased
from Mar. 2023 (52.89) to Mar. 2024 (54.76).
Pulmonx Days Sales Outstanding Historical Data
The historical data trend for Pulmonx's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pulmonx's Days Sales Outstanding
For the Medical Devices subindustry, Pulmonx's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulmonx's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pulmonx's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Pulmonx's Days Sales Outstanding falls into.
Pulmonx Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulmonx (NAS:LUNG) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Pulmonx Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of Pulmonx's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LUNG has been successfully added to your 